MX156277A - Procedimiento mejorado para preparar estearato de acetil eritromicina - Google Patents

Procedimiento mejorado para preparar estearato de acetil eritromicina

Info

Publication number
MX156277A
MX156277A MX203973A MX20397385A MX156277A MX 156277 A MX156277 A MX 156277A MX 203973 A MX203973 A MX 203973A MX 20397385 A MX20397385 A MX 20397385A MX 156277 A MX156277 A MX 156277A
Authority
MX
Mexico
Prior art keywords
improved procedure
preparing acetyl
erythromycin
acetyl stearate
stearate erythromycin
Prior art date
Application number
MX203973A
Other languages
English (en)
Spanish (es)
Inventor
Martti Lauri Antero Marvela
Esko Veikko Marttila
Jaakko Antero Uotila
Aino Kyllikki Pippuri
Pekka Juhani Kairisalo
Erkki Juhani Honkanen
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of MX156277A publication Critical patent/MX156277A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring (AREA)
MX203973A 1984-01-06 1985-01-07 Procedimiento mejorado para preparar estearato de acetil eritromicina MX156277A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK5884A DK149776C (da) 1984-01-06 1984-01-06 Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen

Publications (1)

Publication Number Publication Date
MX156277A true MX156277A (es) 1988-08-04

Family

ID=8089251

Family Applications (1)

Application Number Title Priority Date Filing Date
MX203973A MX156277A (es) 1984-01-06 1985-01-07 Procedimiento mejorado para preparar estearato de acetil eritromicina

Country Status (38)

Country Link
US (1) US4599326A (OSRAM)
JP (1) JPS60158197A (OSRAM)
KR (1) KR900006237B1 (OSRAM)
AT (1) AT386414B (OSRAM)
AU (1) AU565688B2 (OSRAM)
BE (1) BE901411A (OSRAM)
BG (1) BG43189A3 (OSRAM)
CA (1) CA1224461A (OSRAM)
CH (1) CH666275A5 (OSRAM)
CS (1) CS247191B2 (OSRAM)
CY (1) CY1462A (OSRAM)
DE (1) DE3500179A1 (OSRAM)
DK (1) DK149776C (OSRAM)
ES (1) ES8605818A1 (OSRAM)
FI (1) FI77249C (OSRAM)
FR (1) FR2557878B1 (OSRAM)
GB (1) GB2152502B (OSRAM)
HK (1) HK11590A (OSRAM)
HU (1) HU196221B (OSRAM)
IE (1) IE57967B1 (OSRAM)
IL (1) IL73885A (OSRAM)
IS (1) IS2968A7 (OSRAM)
IT (1) IT1184304B (OSRAM)
KE (1) KE3841A (OSRAM)
LU (1) LU85721A1 (OSRAM)
MA (1) MA20316A1 (OSRAM)
MX (1) MX156277A (OSRAM)
NL (1) NL8403979A (OSRAM)
NO (1) NO160263C (OSRAM)
NZ (1) NZ210606A (OSRAM)
PH (1) PH22471A (OSRAM)
PL (1) PL144349B1 (OSRAM)
PT (1) PT79777B (OSRAM)
RO (1) RO91262B (OSRAM)
SE (1) SE461854B (OSRAM)
SU (1) SU1410866A3 (OSRAM)
YU (1) YU44485B (OSRAM)
ZA (1) ZA8410143B (OSRAM)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
JP4694207B2 (ja) * 2002-07-05 2011-06-08 コルジウム ファーマシューティカル, インコーポレイテッド オピオイドおよび他の薬物に関する乱用抑止性の薬学的組成物
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US8840928B2 (en) 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
AU2004285532A1 (en) * 2003-10-31 2005-05-12 Alza Corporation Administration of levodopa and carbidopa
WO2005123039A1 (en) 2004-06-12 2005-12-29 Collegium Pharmaceutical, Inc. Abuse-deterrent drug formulations
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
EP2457580A1 (en) 2004-08-25 2012-05-30 The UAB Research Foundation Absorption enhancers for drug administration
CA2714867A1 (en) 2006-06-23 2007-12-27 Candace B. Pert Non-aggregated pharmaceutically active peptide
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
JP6148228B2 (ja) 2011-05-18 2017-06-14 ユーメデリス ファーマシューティカルズ,インク. 改善されたペプチド製剤
DK2922877T3 (da) 2012-11-20 2019-01-02 Eumederis Pharmaceuticals Inc Forbedrede peptidlægemidler
BR112015011478B1 (pt) 2012-11-20 2022-10-25 Mederis Diabetes, Llc Produtos de peptídeo, seus usos e composição farmacêutica
WO2014140699A1 (en) * 2013-03-13 2014-09-18 Calyx Chemicals And Pharmaceuticals Ltd A novel process of liberation of erythromycin and preparation of its salts
HUE066179T2 (hu) 2014-05-28 2024-07-28 Mederis Diabetes Llc Javított peptidek inzulinrezisztencia ellen
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations
AU2018270129B2 (en) * 2017-05-19 2021-01-07 Lunella Biotech, Inc. Antimitoscins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
EP3717015A4 (en) 2017-12-01 2021-07-28 Lunella Biotech, Inc. REPURPOSCINS: TARGET MITOCHONDRIAL BIOGENESIS INHIBITORS TO ERADICATE CARCINOUS STEM CELLS
AU2019217643B2 (en) 2018-02-06 2021-10-28 ARS Pharmaceuticals Operations, Inc. Intranasal epinephrine formulations and methods for the treatment of disease
WO2019157099A1 (en) 2018-02-06 2019-08-15 Aegis Therapeutics, Llc Intranasal epinephrine formulations and methods for the treatment of disease
AU2019402099B2 (en) * 2018-12-17 2025-01-23 Lunella Biotech, Inc. Triple combination therapies for anti-aging
KR20210104829A (ko) * 2018-12-17 2021-08-25 루넬라 바이오테크 인코포레이티드 미토콘드리아를 표적화하고 암 줄기 세포를 사멸시키는 삼중 조합 요법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1011117B (de) * 1953-11-16 1957-06-27 Abbott Lab Verfahren zur Herstellung von reinen stabilen Erythromycin-Saeure-Additionssalzen
FR1179208A (fr) * 1953-11-16 1959-05-21 Abbott Lab Procédé de préparation de sels d'érythromycine
GB834397A (en) * 1958-07-29 1960-05-04 Lilly Co Eli Therapeutic compositions comprising erythromycin esters
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
IE57967B1 (en) 1993-06-02
PT79777A (en) 1985-01-01
NO160263C (no) 1989-03-29
GB2152502A (en) 1985-08-07
IS2968A7 (is) 1985-04-03
MA20316A1 (fr) 1985-10-01
US4599326A (en) 1986-07-08
FI77249C (fi) 1989-02-10
NL8403979A (nl) 1985-08-01
IL73885A0 (en) 1985-03-31
AU3705984A (en) 1985-07-11
DK149776B (da) 1986-09-29
PH22471A (en) 1988-09-12
RO91262B (ro) 1987-07-01
LU85721A1 (fr) 1985-07-24
HK11590A (en) 1990-02-23
SE461854B (sv) 1990-04-02
KE3841A (en) 1989-04-07
DK149776C (da) 1987-04-21
AU565688B2 (en) 1987-09-24
CA1224461A (en) 1987-07-21
NO160263B (no) 1988-12-19
IT1184304B (it) 1987-10-28
JPS60158197A (ja) 1985-08-19
NO850007L (no) 1985-07-08
IL73885A (en) 1988-10-31
BE901411A (fr) 1985-04-16
ATA985A (de) 1988-01-15
HU196221B (en) 1988-10-28
SU1410866A3 (ru) 1988-07-15
IE850022L (en) 1985-07-06
GB8432368D0 (en) 1985-02-06
FR2557878B1 (fr) 1988-01-15
IT8519012A0 (it) 1985-01-04
FR2557878A1 (fr) 1985-07-12
HUT37628A (en) 1986-01-23
ES539349A0 (es) 1986-04-01
PL251457A1 (en) 1985-11-05
DK5884D0 (da) 1984-01-06
RO91262A (ro) 1987-06-30
PL144349B1 (en) 1988-05-31
CS247191B2 (en) 1986-12-18
ES8605818A1 (es) 1986-04-01
YU2085A (en) 1987-12-31
DK5884A (da) 1985-07-07
ZA8410143B (en) 1985-08-28
PT79777B (en) 1986-10-21
CY1462A (en) 1989-07-21
BG43189A3 (en) 1988-04-15
CH666275A5 (de) 1988-07-15
SE8406671L (sv) 1985-07-07
NZ210606A (en) 1987-08-31
GB2152502B (en) 1987-10-07
KR900006237B1 (ko) 1990-08-27
AT386414B (de) 1988-08-25
SE8406671D0 (sv) 1984-12-28
YU44485B (en) 1990-08-31
JPH029040B2 (OSRAM) 1990-02-28
FI850023A0 (fi) 1985-01-03
DE3500179A1 (de) 1985-07-18
KR850005452A (ko) 1985-08-26
FI77249B (fi) 1988-10-31
FI850023L (fi) 1985-07-07
DE3500179C2 (OSRAM) 1989-08-24

Similar Documents

Publication Publication Date Title
MX156277A (es) Procedimiento mejorado para preparar estearato de acetil eritromicina
MX159807A (es) Procedimiento para preparar derivados de bencimidazol
ES544204A0 (es) Procedimiento para preparar dialcoxipiridinas
MX163384B (es) Procedimiento para preparar esteres de gangliosidos
ES542976A0 (es) Procedimiento para preparar pirrolo-bencimidazoles
MX156153A (es) Procedimiento para producir derivados de carboestirilo
ES526827A0 (es) Procedimiento para preparar derivados de n-fenilpirazol
AR227316A1 (es) Procedimiento para preparar antibioticos de macrolida
ES540464A0 (es) Procedimiento para preparar derivados de pleuromutilina
ES550730A0 (es) Procedimiento para preparar poliesterpolioles
MX158198A (es) Procedimiento para preparar derivados de amidinopiperidina
ES549975A0 (es) Procedimiento para preparar n-formil-&-aspartil fenilalanina
ES555562A0 (es) Procedimiento para preparar celalosporinas
ES542138A0 (es) Procedimiento de preparar compuestos oxima o-substituida
MX159654A (es) Procedimiento para preparar derivados de hidroxi-4-2h-1-benzotiopiran-2-onas
MX160612A (es) Procedimiento para preparar 3-carbonil-1-aminoalquil-1h-indoles
ES543985A0 (es) Procedimiento para preparar derivados de butiramida
ES552676A0 (es) Un procedimiento para preparar glicosidos
ES544074A0 (es) Procedimiento para preparar naftoxacinas
ES549076A0 (es) Procedimiento para preparar derivados de fenilpiperazina
MX159907A (es) Procedimiento para preparar cloro-o-nitroanilinas
ES557069A0 (es) Procedimiento para preparar derivados de benzazol
ES544581A0 (es) Procedimiento para preparar derivados de isoquinolina.
ES555042A0 (es) Procedimiento para preparar diazepinoindoles
ES546647A0 (es) Procedimiento para preparar pseudooligosacaridos